BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 10573118)

  • 1. Retinoic acid receptor antagonist BMS453 inhibits the growth of normal and malignant breast cells without activating RAR-dependent gene expression.
    Yang L; Munoz-Medellin D; Kim HT; Ostrowski J; Reczek P; Brown PH
    Breast Cancer Res Treat; 1999 Aug; 56(3):277-91. PubMed ID: 10573118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The retinoic acid receptor antagonist, BMS453, inhibits normal breast cell growth by inducing active TGFbeta and causing cell cycle arrest.
    Yang L; Ostrowski J; Reczek P; Brown P
    Oncogene; 2001 Nov; 20(55):8025-35. PubMed ID: 11753686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of retinoid resistance in breast cancer cells by overexpression of cJun.
    Yang L; Kim HT; Munoz-Medellin D; Reddy P; Brown PH
    Cancer Res; 1997 Oct; 57(20):4652-61. PubMed ID: 9377582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.
    Wu Q; Dawson MI; Zheng Y; Hobbs PD; Agadir A; Jong L; Li Y; Liu R; Lin B; Zhang XK
    Mol Cell Biol; 1997 Nov; 17(11):6598-608. PubMed ID: 9343423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
    Schneider SM; Offterdinger M; Huber H; Grunt TW
    Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
    Wan H; Dawson MI; Hong WK; Lotan R
    Oncogene; 1997 Oct; 15(17):2109-18. PubMed ID: 9366527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
    Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP
    Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All-trans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use.
    Giannini F; Maestro R; Vukosavljevic T; Pomponi F; Boiocchi M
    Int J Cancer; 1997 Jan; 70(2):194-200. PubMed ID: 9009160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
    Wan H; Hong WK; Lotan R
    Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids.
    Le Q; Dawson MI; Soprano DR; Soprano KJ
    Oncogene; 2000 Mar; 19(11):1457-65. PubMed ID: 10723137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
    Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
    Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine modulates the effects of retinoids on growth inhibition and RAR beta expression in lung cancer cells.
    Chen GQ; Lin B; Dawson MI; Zhang XK
    Int J Cancer; 2002 May; 99(2):171-8. PubMed ID: 11979430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
    Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells.
    Chattopadhyay N; Butters RR; Brown EM
    Brain Res Mol Brain Res; 2001 Feb; 87(1):100-8. PubMed ID: 11223164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of retinoic acid receptor-gamma selectively binding retinoids alone and in combination with interferon-gamma in breast cancer cell lines.
    Widschwendter M; Daxenbichler G; Culig Z; Michel S; Zeimet AG; Mörtl MG; Widschwendter A; Marth C
    Int J Cancer; 1997 May; 71(3):497-504. PubMed ID: 9139890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acid-induced apoptosis in human breast cancer cells.
    Li Y; Hashimoto Y; Agadir A; Kagechika H; Zhang Xk
    J Biol Chem; 1999 May; 274(22):15360-6. PubMed ID: 10336422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
    Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
    Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells.
    de Vos S; Dawson MI; Holden S; Le T; Wang A; Cho SK; Chen DL; Koeffler HP
    Prostate; 1997 Jul; 32(2):115-21. PubMed ID: 9215399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
    Lee HY; Dawson MI; Walsh GL; Nesbitt JC; Eckert RL; Fuchs E; Hong WK; Lotan R; Kurie JM
    Cell Growth Differ; 1996 Aug; 7(8):997-1004. PubMed ID: 8853895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of receptor-selective retinoids on growth and differentiation pathways in mouse melanoma cells.
    Desai SH; Boskovic G; Eastham L; Dawson M; Niles RM
    Biochem Pharmacol; 2000 May; 59(10):1265-75. PubMed ID: 10736427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.